PACS PACS Group, Inc.
$44.76
Platform & Compounding FCF 85%
Two-stage FCF DCF
Mild · Conviction

Fair Value

Trading 10.8% below fair value

You pay $44.76
Bear $20.09
Fair $50.17
Bull $86.53
Bear $20.09 -55.1% 11% stage 1 growth, 11% discount
Fair $50.17 +12.1% 18% stage 1 growth, 11% discount
Bull $86.53 +93.3% 24% stage 1 growth, 11% discount

Adjust Assumptions

18.4%
11.0%
3.0%

Key Value Driver

FCF growth rate (18% base case)

Terminal Value % of EV 45%
Implied Market Multiple 37.4x
Market is pricing in (growth) 17.3% vs 18.4% base

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above.

Average Target (8 analysts) $56.67
Divergence from AlphaVal 11%

Summary

Using a two-stage FCF DCF with 18% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $50.17 per share.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions